Neurosoft Bioelectronics: Funding, Investors & Team (Sep 2026)
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system. Neural implants are medical devices made of electrodes that can record or stimulate the brain, spinal cord, or peripheral nerves to monitor or treat patients suffering from neurological disorders. However, current clinical devices are too stiff compared to the soft tissues of the body, which limits benefits for patients. At Neurosoft Bioelectronics, we have developed a new generation of soft and conformable implantable electrodes that seamlessly interface with the nervous tissues and can improve clinical outcomes for patients.
Neurosoft Bioelectronics has raised $7.6M across 2 funding rounds on record, the most recent a Seed of $7.5M announced in May 2026.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Neurosoft Bioelectronics Company Profile and Key Stats
Latest funding round on record: May 2026.
Neurosoft Bioelectronics Funding Rounds
Neurosoft Bioelectronics raised $100k in a Convertible Note announced in Dec 2021.
4.4 years later, a Seed of $7.5M was announced in May 2026.
Neurosoft Bioelectronics Founders and Leadership Team
Contact details for the Neurosoft Bioelectronics team: 1 of 1 has an email address on file.
Start 14-day free trial →Neurosoft Bioelectronics Funding Compared to Other Biotechnology Startups
Neurosoft Bioelectronics' latest round of $7.5M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Neurosoft Bioelectronics in Biotechnology and Geneva
Companies Similar to Neurosoft Bioelectronics
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Pharvaris is a clinical-stage company working on bringing a new oral bradykinin B2 receptor antagonist to…
Neurosoft Bioelectronics Funding FAQs
What does Neurosoft Bioelectronics do?
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the nervous system. Neural implants are medical devices made of electrodes that can record or stimulate the brain, spinal cord, or peripheral nerves to monitor or treat patients suffering from neurological disorders. However, current clinical devices are too stiff compared to the soft tissues of the body, which limits benefits for patients. At Neurosoft Bioelectronics, we have developed a new generation of soft and conformable implantable electrodes that seamlessly interface with the nervous tissues and can improve clinical outcomes for patients.
How much funding has Neurosoft Bioelectronics raised?
Neurosoft Bioelectronics has raised $7.6M across 2 rounds on record. The most recent is a Seed of $7.5M announced in May 2026.
When did Neurosoft Bioelectronics last raise funding?
Neurosoft Bioelectronics' most recent funding round on record is a Seed of $7.5M, announced in May 2026.
Who is the CEO of Neurosoft Bioelectronics?
Nicolas Vachicouras is listed as CEO at Neurosoft Bioelectronics.
Where is Neurosoft Bioelectronics headquartered?
Neurosoft Bioelectronics is based in Geneva, Geneve, Switzerland.
How many employees does Neurosoft Bioelectronics have?
Neurosoft Bioelectronics is in the 1-10 employee band.
How does Neurosoft Bioelectronics' funding compare to other Biotechnology startups?
Neurosoft Bioelectronics' latest round of $7.5M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Neurosoft Bioelectronics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neurosoft Bioelectronics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.